Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_assertion type Assertion NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_head.
- NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_assertion description "[A preferred panel would also include CD20, CD117, CD28 and CD27; 4) discrepancies between the percentage of plasma cells detected by flow cytometry and morphology are primarily related to sample quality and it is, therefore, important to determine that marrow elements are present in follow-up samples, particularly normal plasma cells in MRD negative cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_provenance.
- NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_assertion evidence source_evidence_literature NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_provenance.
- NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_assertion SIO_000772 18268286 NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_provenance.
- NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_assertion wasDerivedFrom befree-2016 NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_provenance.
- NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_assertion wasGeneratedBy ECO_0000203 NP654993.RAVjwlDZ-HDAUE5yDfjSX-LBV747sg7aJ49ClwbfxwuT0130_provenance.